CALABRESI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 511
EU - Europa 490
AS - Asia 88
AF - Africa 1
SA - Sud America 1
Totale 1.091
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 510
PL - Polonia 220
IT - Italia 96
IE - Irlanda 44
SE - Svezia 35
CH - Svizzera 30
HK - Hong Kong 26
RU - Federazione Russa 24
CN - Cina 22
SG - Singapore 18
DE - Germania 12
GB - Regno Unito 11
JO - Giordania 11
FR - Francia 6
VN - Vietnam 6
BE - Belgio 4
FI - Finlandia 4
KR - Corea 4
ES - Italia 2
BR - Brasile 1
CA - Canada 1
IN - India 1
MU - Mauritius 1
NL - Olanda 1
UA - Ucraina 1
Totale 1.091
Salva come PNG Salva come JPEG
Città #
Warsaw 220
Fairfield 73
Chandler 52
Dublin 44
Ashburn 39
Florence 37
Woodbridge 37
Seattle 35
Houston 33
Ann Arbor 30
Cambridge 30
Bern 28
Wilmington 24
Hong Kong 18
Altamura 14
Lawrence 14
Princeton 11
Beijing 10
Bremen 10
Buffalo 9
Boston 8
Los Angeles 8
Singapore 7
Dong Ket 6
Kent 6
Moscow 6
New York 6
Dearborn 5
Brussels 4
Cagliari 4
San Diego 4
Seoul 4
Boardman 3
Hillsboro 3
Redwood City 3
San Jose 3
Shanghai 3
Basel 2
Cantagallo 2
Cusano Milanino 2
Ealing 2
Falls Church 2
Fiesole 2
Kunming 2
Medford 2
Phoenix 2
Reston 2
Romainville 2
Seville 2
Andover 1
Augusta 1
Bethesda 1
Corato 1
Falkenstein 1
Fiumicino 1
Fontebuona 1
Jacksonville 1
Lappeenranta 1
Livorno 1
Monteroni D'arbia 1
Montreal 1
Nanchang 1
Noisy-le-sec 1
Pisa 1
Pune 1
Rome 1
Salerno 1
Scarperia e San Piero 1
Schiavon 1
Shenzhen 1
Signa 1
São Paulo 1
Tappahannock 1
Wandsworth 1
Xian 1
Xuzhou 1
Totale 902
Salva come PNG Salva come JPEG
Nome #
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis 235
Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in JAK2V617F mutated cells through PP2A/ CIP2A axis 151
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 145
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 102
Characterization of novel molecular targets and mechanisms in Philadelphia-negative Myeloproliferative Neoplasms 100
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 85
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value. 85
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature 73
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs 48
Molecular Characterization of Response/Loss-of-Response to Ruxolitinib in Patients with Myelofibrosis 33
The MPL mutation 28
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 18
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms 7
Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cells 3
Totale 1.113
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.854
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020234 0 16 7 15 29 37 25 39 23 13 25 5
2020/2021156 9 23 4 20 11 16 8 10 15 23 7 10
2021/202270 1 2 8 0 2 4 0 7 5 6 14 21
2022/2023268 15 51 14 22 15 34 30 14 29 2 9 33
2023/2024132 2 15 15 5 12 16 1 37 4 5 13 7
2024/202540 27 13 0 0 0 0 0 0 0 0 0 0
Totale 1.113